Sienna Biopharmaceuticals (SNNA) PT Lowered to $3 at BMO Capital
Tweet
Share
E-mailGet Alerts SNNA Hot Sheet
Price: $0.14 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
BMO Capital analyst Gary Nachman lowered the price target on Sienna Biopharmaceuticals (NASDAQ: SNNA) to $3.00 (from $9.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
- CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results
- Nebius Group (NBIS) PT Raised to $250 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
